BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Export Sales of Curasan Continue to Rise

  curasan AG has further consolidated its export business in the third quarter.

  December 4, 2017

   · 

  4 min read
• Array BioPharma Announces Redemption of All Remaining 3.00% Convertible Senior Notes Due 2020

  The redemption will be made in accordance with the terms of the indenture governing the 2020 Notes and the terms of the redemption notice.

  December 4, 2017

   · 

  3 min read
• NanoSphere Health Sciences Announces Name Change, CSE Listing and Conversion of %5.9M in Subscription Receipts

  NanoSphere’s shares will commence trading tomorrow, December 5, 2017, under the symbol “NSHS”.

  December 4, 2017

   · 

  5 min read
• 

  Business

  Gilead Commits $100M to Tackle the HIV/AIDS Epidemic in the Southern U.S.

  Gilead will partner with three coordinating centers to lead the corporate giving program of the initiative.

  December 4, 2017

   · 

  6 min read
• Drug Development

  Seres Therapeutics Announces FDA Orphan Drug Designation for SER-287 in Treatment of Pediatric Ulcerative Colitis

  The FDA’s designation of SER-287 follows a review of data which established a medically plausible basis for the use of SER-287.

  December 4, 2017

   · 

  6 min read
• Spectrum Pharmaceuticals Highlights 15 Abstracts at the 59th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia, December 9-12, 2017

  Spectrum Pharmaceuticals announced key presentations of clinical and scientific data related to its products at the 59th Annual Meeting of the American Society of Hematology (ASH), being held in Atlanta, Georgia, from December 9-12, 2017.

  December 4, 2017

   · 

  6 min read
• Business

  Ncardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS Cells

  Under the terms of the agreement, Evotec has broad access to Ncardia’s stem cell derived cellular disease modelling IP.

  December 4, 2017

   · 

  3 min read
• Drug Development

  Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects

  These studies confirm a pharmacokinetic profile of IW-1973 supporting once-daily dosing and suggest broad distribution to tissues, offering the potential for extra-vascular pharmacology.

  December 4, 2017

   · 

  10 min read
• Deals

  Exactech and TPG Capital Announce Amended Merger Agreement Providing for Increase in Merger Consideration to $49.25 Per Share

  Exactech announced today that it has entered into an amendment to its merger agreement with TPG Capital and certain of its affiliates which was previously announced on October 23, 2017.

  December 4, 2017

   · 

  9 min read
• 

  Drug Development

  AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study

  Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries.

  December 4, 2017

   · 

  6 min read